Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

MedWellAI (MWAI) Cash & Equivalents (2016 - 2025)

MedWellAI (MWAI) has disclosed Cash & Equivalents for 11 consecutive years, with $137503.0 as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents fell 41.37% to $137503.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $137503.0, a 41.37% decrease, with the full-year FY2025 number at $401310.0, up 594.13% from a year prior.
  • Cash & Equivalents was $137503.0 for Q4 2025 at MedWellAI, down from $223221.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $2.1 million in Q2 2021 to a low of $27452.0 in Q4 2023.
  • A 5-year average of $355485.2 and a median of $228870.0 in 2024 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 31323.78% in 2021, then plummeted 79.47% in 2022.
  • MedWellAI's Cash & Equivalents stood at $155729.0 in 2021, then crashed by 44.2% to $86891.0 in 2022, then crashed by 68.41% to $27452.0 in 2023, then surged by 754.29% to $234519.0 in 2024, then crashed by 41.37% to $137503.0 in 2025.
  • Per Business Quant, the three most recent readings for MWAI's Cash & Equivalents are $137503.0 (Q4 2025), $223221.0 (Q3 2025), and $401310.0 (Q2 2025).